English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduAn analysis of data from the REPRIEVE statin trial found that metabolic risk factors strongly contributed to the increased cases of new-onset diabetes among people with HIV (PWH).
Tag: HIV
First report of its kind describes HIV reservoir landscape in breast milk
In the first report of its kind, researcher from the University of Buenos Aires evaluated the HIV reservoir in the breast milk cells of two women living with HIV (WLWH) who had been on successful long-term treatment.
Study Finds Telehealth Effective for HIV Patients
Essex County data show that HIV patients maintained their health with remote care during the COVID-19 pandemic.
“We Can Reverse Latino HIV Crisis,” Guilamo-Ramos
Prof. Vincent Guilamo-Ramos, PhD RN Executive Director of the Institute for Policy Solutions (IPS) at Johns Hopkins School of Nursing, joined a diverse group of leaders at the White House today to shine the spotlight on the largely invisible HIV crisis in the Latino community.
Triple Antibody Therapy Shows Promise for Long-Lasting HIV Control
In a study of 12 participants, researchers at Beth Israel Deaconess Medical Center (BIDMC) have demonstrated that a cocktail of three broadly neutralizing antibodies (bNAb) successfully suppressed virus in people living with HIV. A subset of participants also demonstrated long-term control of the virus months after antibody levels declined to low or undetectable.
£2 million grant to research reducing AIDS-related deaths caused by bacterial and fungal infections
Professor Nelesh Govender was awarded one of 7 prestigious 5-year UK National Institute for Health and Care Research (NIHR) Global Research Professorships.
Breaking research on the use of race in prenatal screens, health outcomes of HIV-exposed children could advance healthcare for underserved populations
In a new study, researchers have demonstrated that there is an insufficient basis for incorporating race in prenatal screening for birth defects. In a second, separate study, researchers have found that HIV-exposed uninfected children are at higher risk for health problems compared to uninfected, unexposed children.
Sylvester Science Contributes to Guidelines for Anal Cancer
Federal health officials recently released new guidelines for anal cancer screening to protect people with HIV, an achievement made possible by a landmark study conducted at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, and Jackson Memorial Hospital, and other research institutions.
New Study Determines Incidence of and Risk Factors for Hepatitis C Virus Reinfection Among Men with HIV, Offers New Insight on Transmission
A new study determines incidence of and risk factors for hepatitis C virus reinfection among men with HIV, and offers new insight on transmission.
Hepatitis C Virus Reinfection Among Men Who Have Sex With Men With HIV in New York City
Abstract Background Hepatitis C virus (HCV) reinfection rates are substantially higher than primary infection rates among men who have sex with men (MSM) with human immunodeficiency virus (HIV) in European cohorts. The behaviors mediating this high rate of transmission among…
Accurate sexual health information on TikTok? It’s this UCLA doctor’s mission
UCLA Health’s Dr. Russell Johnson educates and empowers on TikTok with accurate sexual health information Dr. Russell Johnson, UCLA Health primary care physician and HIV and sexual health expert, is available for interview on the following topics: Intersection of medicine,…
Voluntary circumcision effective for preventing HIV infection among men who have sex with men
A randomized controlled trial comprised of 247 men who have sex with men (MSM) found that voluntary medical male circumcision (VMMC) can prevent incident HIV infection. These findings suggest that MSM should be included in VMMC guidelines. The study is published in Annals of Internal Medicine.
Study that empowers traditional health practitioners to test for HIV expands in rural South Africa
A National Institutes of Health five-year, $2.8 million grant to Wits and Vanderbilt University will advance traditional health practitioner-initiated HIV testing.
Mount Sinai’s Yvette Calderon, MD, MS, Receives Prestigious Award From Society for Academic Emergency Medicine
Top honor recognizes her commitment to justice, equity, diversity, and inclusion through scholarship, mentorship, and leadership
ChatGPT can be helpful for Black women’s self-education about HIV, PrEP
The artificial intelligence (AI) chatbot called ChatGPT is a powerful way for Black women to educate themselves about HIV prevention, as it provides reliable and culturally sensitive information, according to a study in The Journal of the Association of Nurses in AIDS Care (JANAC), the official journal of the Association of Nurses in AIDS Care.
Semaglutide suitable for people with HIV and fatty liver disease
A study of persons with HIV (PWH) and metabolic dysfunction–associated steatotic liver disease, also known as ‘fatty liver disease,’ (MASLD) found that semaglutide was highly effective at reducing liver fat and cardiovascular disease risk in this population.
Bird Flu Basics: Safety, Symptoms and Risks
The highly infectious bird flu, also known as avian influenza H5N1, primarily spreads among birds. However, there have been rare cases of infection to humans. According to the Centers for Disease Control and Prevention, two human cases of H5N1 have…
Perinatal Transmission of HIV Can Lead to Cognitive Deficits
Perinatal transmission of HIV to newborns is associated with serious cognitive deficits as children grow older, according to a detailed analysis of 35 studies conducted by Georgetown University Medical Center neuroscientists. The finding helps pinpoint the geographic regions and factors that may be important for brain development outcomes related to perinatal HIV infection: mother-to-child HIV transmission during pregnancy, labor and delivery, or breastfeeding.
Common HIV treatments may aid Alzheimer’s disease patients
Scientists at Sanford Burnham Prebys have now identified promising real-world links between common HIV drugs and a reduced incidence of Alzheimer’s disease. The study, led by Jerold Chun, M.D., Ph.D., was published in Pharmaceuticals.
Wistar Scientists Identify Pro-aging ‘Sugar Signature’ in the Blood of People Living with HIV
Wistar’s Dr. Abdel-Mohsen has identified sugar abnormalities in the blood that may promote biological aging and inflammation in people living with HIV.
Physicians debate best management strategy for patient at risk for HIV exposure
In a new Annals ‘Beyond the Guidelines’ feature, two physicians experienced in HIV antiretroviral pre-exposure prophylaxis (PrEP) debate how best to identify those patients who might benefit from PrEP, how to decide what regimen to use, and how to monitor therapy.
Case Western Reserve global health expert available to speak about World Health Day
Robert A. Salata, MD is the STERIS Chair of Excellence in Medicine and Chairman of the Department of Medicine since 2015 and was Chief of the Division of Infectious Diseases and HIV Medicine for nearly 20 years at Case Western Reserve…
Wake Forest University School of Medicine, Advocate Health and Vysnova Partners Awarded $3.4 Million Contract by CDC to Lead Large-Scale Sexually Transmitted Infection Research Project
Wake Forest University School of Medicine, Advocate Health and Vysnova Partners have been awarded a $3.4 million, four-year contract to study HIV, Mpox and other sexually transmitted infections (STIs).
Researchers a step closer to a cure for HIV
In a first, the study published in the journal Emerging Microbes and Infections demonstrated the team’s patented therapeutic candidate, an HIV-virus-like-particle (HLP), is 100 times more effective than other candidate HIV cure therapeutics for people living with chronic HIV on combined antiretroviral therapy (cART).
Study Shows HIV Remission Is Possible for Children Started on Very Early Antiretroviral Therapy
Research co-led by an investigator at Johns Hopkins Children’s Center shows that four children born with HIV who were safely removed from antiretroviral therapy (ART) continued to have undetectable levels of the virus for about a year or more without treatment. The children were among 54 newborns who were given very early treatment within the first 48 hours of life — rather than within weeks or months, as is typical.
[email protected]
Measles: How to Spot it, When to Seek Care and Importance of Vaccination
As the Measles outbreak continues to grow in Florida, Francesca Torriani, MD, infectious disease specialist with UC San Diego Health is available to discuss symptoms to look out for, when to seek medical care, and the importance of vaccination. Biography…
Researchers are using RNA in a new approach to fight HIV
Society learned about the value of mRNA during the COVID-19 pandemic when we saw scientists and medical professionals harness its power to deliver a vaccine for the virus within a year.
Droughts may trigger HIV transmission increase among women in rural sub-Saharan Africa, study finds
Droughts have the potential to increase the spread of HIV for women living in rural parts of Africa, researchers at the University of Bristol have found.
Study Reveals Accelerated Aging in Women Living With HIV
Women with HIV experience accelerated DNA aging, a phenomenon that can lead to poor physical function, according to a study led by Stephanie Shiau, an assistant professor in the Department of Biostatistics and Epidemiology at the Rutgers School of Public Health.
Prof. Dr. Thanyavee Puthanakit, National Outstanding Researcher in Medical Science, with Clinical Research on the Treatment and Prevention of HIV in Youth
Prof. Dr. Thanyavee expressed her appreciation and honor for receiving the Outstanding Researcher Award.
Better diagnosis and treatment of cryptococcosis
A group of international mycology experts led by Professor Dr Oliver A. Cornely at the University of Cologne has jointly drafted a guideline for the diagnosis and treatment of cryptococcosis, which aims at improving infection management and thus the survival rate of patients.
Fighting Viruses that Cause Cancer
In research labs and clinical settings, faculty across Tufts School of Medicine and Graduate School of Biomedical Sciences are investigating cancer caused by herpes, HIV, HPV, and other viruses
Fiber, the Gut, Heart Disease and HIV
Investigators from Cedars-Sinai have made two important discoveries about fiber and the gut microbiome in patients with human immunodeficiency virus, or HIV.
Integrated chronic care in Africa can improve outcomes and save money
Across Africa about two million premature deaths each year are caused by the effects of diabetes and hypertension.
Mount Sinai Awarded $3.4 Million to Study Prostate Cancer in People With HIV
The National Cancer Institute has awarded the Icahn School of Medicine at Mount Sinai a $3.4 million grant to create a model that identifies the best prostate cancer treatment for people with HIV.
Traditional healers in rural Mpumalanga help diagnose HIV
An initiative of Wits University’s MRC/Wits Agincourt Research Unit, the Traditional Healers Project convened two ‘open houses’ at local primary healthcare facilities – Rolle Clinic and Thulamahashe Community Health Centre in rural Bushbuckridge, Mpumalanga – in March 2023.
New Community Partnership Model Boosts Inclusion of Participants into HIV Cure-Directed Research
Scientists have long used community advisory boards to engage communities and provide feedback on studies, but this model has limitations. Now, Wistar Institute researchers are sharing how a more inclusive model for community engagement can lead to deeper insights and greater community participation in HIV research.
Gender, race and socioeconomic status are associated with comorbidity in people with HIV who smoke
High rates of smoking among people with HIV are associated with high rates of comorbid health problems – which are associated with characteristics including gender, race/ethnicity, and socioeconomic status, according to a study in the July issue of The Journal of the Association of Nurses in AIDS Care (JANAC). The official journal of the Association of Nurses in AIDS Care, JANAC is published in the Lippincott portfolio by Wolters Kluwer.
Preclinical Studies Led by Johns Hopkins Medicine Researchers Advance Potential New Target to Treat HIV Infection
Researchers at Johns Hopkins Medicine, in collaboration with researchers at the National Institutes of Health, report that two new studies in mice with a humanized immune system and human cell lines have identified an enzyme that plays a critical role in the late stages of HIV replication.
Rensselaer Researcher Uses Pressure To Understand RNA Dynamics
Just as space holds infinite mysteries, when we zoom in at the level of biomolecules (one trillion times smaller than a meter), there is still so much to learn.Rensselaer Polytechnic Institute’s Catherine Royer, Constellation Chair Professor of Bioinformatics and Biocomputation at the Shirley Ann Jackson, Ph.D. Center for Biotechnology and Interdisciplinary Studies (CBIS) and professor of biological sciences, is dedicated to understanding the conformational landscapes of biomolecules and how they modulate cell function.
Penile HIV Infection is Effectively Prevented by Antiretroviral Treatment
Researchers at the UNC School of Medicine’s International Center for the Advancement of Translational Science and the Institute for Global Health and Infectious Diseases have developed a new approach for the detailed evaluation of HIV infection throughout the entire male genital tract, HIV acquisition via the penis and the efficient prevention of penile HIV infection. The study was published in mBio by the American Society of Microbiology.
One step closer to eliminating latency, the real challenge in combating HIV
An international study led by MELIS-UPF researchers from the Infection Biology and Molecular Virology laboratories has identified and characterized Schlafen 12 (SLFN 12) as a novel HIV restriction factor.
Rutgers Experts Aim to Uncover Barriers to Conducting HIV Research in Africa
Rutgers Institute for Health researcher, Dr. Ashley Grosso, receives grant from NIH to conduct study on barriers to HIV research in Africa.
Tuberculosis disease intensifies HIV antibody response in people with HIV
New research from Boston Medical Center found that people living with HIV that have had pulmonary tuberculosis had broader and more potent HIV antibody responses and differences in HIV sequences predicted to be antibody resistant as compared to those without suspected or documented tuberculosis.
Mpox Antiviral Outcomes Are Similar Regardless of HIV Status
Patients with mpox who were treated with the antiviral drug tecovirimat had similar outcomes regardless of HIV status, find researchers at Columbia University and Weill Cornell Medicine.
Late HIV diagnosis still an issue in Aotearoa
Forty per cent of people diagnosed with HIV in Aotearoa between 2011 and 2020 were diagnosed late, a University of Otago study shows.
HIV and hepatitis C virus monitoring needs to increase to achieve global elimination goals
Countries must intensify efforts to track HIV and hepatitis C virus (HCV) incidence among people who inject drugs, and to prioritise this group in prevention and elimination work, according to new University of Bristol-led research, published online in The Lancet Gastroenterology & Hepatology.
A readily available dietary supplement may reverse organ damage caused by HIV and antiretroviral therapy
MitoQ, a mitochondrial antioxidant that is available to the public as a diet supplement, was found in a mouse study to reverse the detrimental effects that HIV and antiretroviral therapy (ART) have on mitochondria in the brain, heart, aorta, lungs, kidney and liver.
Texas Biomed HIV vaccine candidate aims to block virus before it takes root
The National Institutes of Health has awarded $3.8 million to Texas Biomedical Research Institute to further develop a promising HIV vaccine candidate that stops the virus upon entry, before it begins rapidly spreading throughout the body.
CDC-UNC Collaboration Yields Potential Long-term HIV Protection
Since 2017, the lab of Rahima Benhabbour, PhD, MSc, associate professor in the UNC/NCSU Joint Department of Biomedical Engineering, has been working with a research team at the Centers for Disease Control and Prevention (CDC) and others at UNC to develop an injectable implant that can release HIV pre-exposure prophylaxis (PrEP) medications into the body for a long period of time.
Their latest research, published in Nature Communications, shows that the team’s latest formulation can provide up to six months of full protection.